Illness	Number of cases
Other malignant neoplasms of skin (C44.3)	190
Other dermatitis - Infective dermatitis (L30.3)	121
Erysipelas (A46)	99
Other malignant neoplasms of skin (C44.4)	96
Malignant melanoma of skin (C43.5)	79
Malignant melanoma of skin (C43.6)	75
Other dermatitis - Other specified dermatitis (L30.8)	61
Zoster herpes zoster (B02.3)	57
Malignant melanoma of skin (C43.7)	48
Atopic dermatitis (L20.8)	46

Top 10 treatments

Treatment	Number
Interdisciplinary management of a skin disease (8-971.0)	424
Temporary covering of soft tissue injuries with skin or artificial skin (5-916.74)	223
(9-984.7)	199
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.14)	183
(9-984.8)	172
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.4a)	81
Skin grafting from the area around the wound (5-903.64)	80
Surgical removal of the nose (5-213.1)	74
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.44)	73
Imaging procedure to show the lymphatic system by means of radioactivity (scintigraphy) (3-709.00)	70

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ02
CQ03	über Tumorboard
CQ05	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org
CQ25
CQ04

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
295	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
212	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
187	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Lehre und Lehrauftrag an den Universitäten Jena, Frankfurt, Freiburg, Regensburg, Greifswald, Technische Universität Ilmenau
Lectureships / teaching posts at universities of applied sciences	Mentorenprojekt der LÄK Thüringen, EANS-Observership-Programm (mit internationalen Fachärzten und AiW)
Project-related cooperation with colleges and universities	u.a.Uni Jena, Uni Leipzig, IMTEK Freiburg, Neurochirurgie Uni Freiburg, HNO Uni Saarbrücken, Psychologie Uni Giessen, Neurofibromatoseambulanz Uni Hamburg
Participation in multi-centre Phase I/II studies	u.a. ADRISK: Multicenter randomized Phase II study within the German interdisciplinary study group of German Cancer Society (IAG KHT) IMSTAR HN: Multicenter randomized controlled phase III study.
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Uni Jena, Uni Leipzig
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks	u.a. Lehrbuch Biomedizinische Technik, Band XI: Neurotechnik
Doctoral supervision	Universitätsmedizin Jena, Greifswald